BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9930319)

  • 1. Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo.
    Ständer M; Naumann U; Dumitrescu L; Heneka M; Löschmann P; Gulbins E; Dichgans J; Weller M
    Gene Ther; 1998 Sep; 5(9):1187-94. PubMed ID: 9930319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
    Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
    Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta-independent induction of immunogenicity by decorin gene transfer in human malignant glioma cells.
    Münz C; Naumann U; Grimmel C; Rammensee HG; Weller M
    Eur J Immunol; 1999 Mar; 29(3):1032-40. PubMed ID: 10092108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
    Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
    Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1.
    Yamamoto T; Eckes B; Krieg T
    Biochem Biophys Res Commun; 2001 Feb; 281(1):200-5. PubMed ID: 11178980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
    Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
    Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor-beta-independent pathway of tumor cell-mediated immunosuppression.
    Huber D; Philipp J; Fontana A
    J Immunol; 1992 Jan; 148(1):277-84. PubMed ID: 1727872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.
    Jahanyar J; Joyce DL; Southard RE; Loebe M; Noon GP; Koerner MM; Torre-Amione G; Youker KA
    J Heart Lung Transplant; 2007 Jan; 26(1):34-40. PubMed ID: 17234515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decorin gene transfer inhibited the expression of TGFbeta1 and ECM in rat mesangial cells.
    Wu F; Yao H; Bader A; Dong F; Zhu F; Wu N; Wang B; Li H; Brockmeyer NH; Altmeyer P
    Eur J Med Res; 2007 Aug; 12(8):360-8. PubMed ID: 17933714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration.
    Engel S; Isenmann S; Ständer M; Rieger J; Bähr M; Weller M
    J Neuroimmunol; 1999 Sep; 99(1):13-8. PubMed ID: 10496172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of overexpression of decorin on matrix metalloproteinases 2 and 9 in rat mesangial and tubular cells].
    Dong FQ; Li H; Wu F; Yao HP
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3444-7. PubMed ID: 19159581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatopontin interacts with transforming growth factor beta and enhances its biological activity.
    Okamoto O; Fujiwara S; Abe M; Sato Y
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):537-41. PubMed ID: 9895299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
    Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
    Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
    Tran TT; Uhl M; Ma JY; Janssen L; Sriram V; Aulwurm S; Kerr I; Lam A; Webb HK; Kapoun AM; Kizer DE; McEnroe G; Hart B; Axon J; Murphy A; Chakravarty S; Dugar S; Protter AA; Higgins LS; Wick W; Weller M; Wong DH
    Neuro Oncol; 2007 Jul; 9(3):259-70. PubMed ID: 17522330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.
    Border WA; Noble NA; Yamamoto T; Harper JR; Yamaguchi Yu; Pierschbacher MD; Ruoslahti E
    Nature; 1992 Nov; 360(6402):361-4. PubMed ID: 1280332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model.
    Biglari A; Bataille D; Naumann U; Weller M; Zirger J; Castro MG; Lowenstein PR
    Cancer Gene Ther; 2004 Nov; 11(11):721-32. PubMed ID: 15475879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse.
    Natsume A; Mizuno M; Ryuke Y; Yoshida J
    Gene Ther; 1999 Sep; 6(9):1626-33. PubMed ID: 10490773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix proteoglycan decorin-mediated myogenic satellite cell responsiveness to transforming growth factor-beta1 during cell proliferation and differentiation Decorin and transforming growth factor-beta1 in satellite cells.
    Li X; McFarland DC; Velleman SG
    Domest Anim Endocrinol; 2008 Oct; 35(3):263-73. PubMed ID: 18650056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.
    Bodmer S; Strommer K; Frei K; Siepl C; de Tribolet N; Heid I; Fontana A
    J Immunol; 1989 Nov; 143(10):3222-9. PubMed ID: 2809198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.